» Articles » PMID: 16893901

Glutaredoxin Modulates Platelet-derived Growth Factor-dependent Cell Signaling by Regulating the Redox Status of Low Molecular Weight Protein-tyrosine Phosphatase

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Aug 9
PMID 16893901
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Glutaredoxin (GRX) is a glutathione-disulfide oxidoreductase involved in various cellular functions, including the redox-dependent regulation of certain integral proteins. Here we demonstrated that overexpression of GRX suppressed the proliferation of myocardiac H9c2 cells treated with platelet-derived growth factor (PDGF)-BB. After stimulation with PDGF-BB, the phosphorylation of PDGF receptor (PDGFR) beta was suppressed in GRX gene-transfected cells, compared with controls. Conversely, the phosphorylation was enhanced by depletion of GRX by RNA interference. In this study we focused on the role of low molecular weight protein-tyrosine phosphatase (LMW-PTP) in the dephosphorylation of PDGFRbeta via a redox-dependent mechanism. We found that depletion of LMW-PTP using RNA interference enhanced the PDGF-BB-induced phosphorylation of PDGFRbeta, indicating that LMW-PTP works for PDGFRbeta. The enhancement of the phosphorylation of PDGFRbeta was well correlated with inactivation of LMW-PTP by cellular peroxide generated in the cells stimulated with PDGF-BB. In vitro, with hydrogen peroxide treatment, LMW-PTP showed decreased activity with the concomitant formation of dithiothreitol-reducible oligomers. GRX protected LMW-PTP from hydrogen peroxide-induced oxidation and inactivation in concert with glutathione, NADPH, and glutathione disulfide reductase. This strongly suggests that retention of activity of LMW-PTP by enhanced GRX expression suppresses the proliferation of cells treated with PDGF-BB via enhanced dephosphorylation of PDGFRbeta. Thus, GRX plays an important role in PDGF-BB-dependent cell proliferation by regulating the redox state of LMW-PTP.

Citing Articles

Disulfide stress and its role in cardiovascular diseases.

Qian S, Chen G, Li R, Ma Y, Pan L, Wang X Redox Biol. 2024; 75:103297.

PMID: 39127015 PMC: 11364009. DOI: 10.1016/j.redox.2024.103297.


Structural and functional fine mapping of cysteines in mammalian glutaredoxin reveal their differential oxidation susceptibility.

Corteselli E, Sharafi M, Hondal R, MacPherson M, White S, Lam Y Nat Commun. 2023; 14(1):4550.

PMID: 37507364 PMC: 10382592. DOI: 10.1038/s41467-023-39664-2.


Role of cassava CC-type glutaredoxin MeGRXC3 in regulating sensitivity to mannitol-induced osmotic stress dependent on its nuclear activity.

Ruan M, Yu X, Guo X, Zhao P, Peng M BMC Plant Biol. 2022; 22(1):41.

PMID: 35057736 PMC: 8772167. DOI: 10.1186/s12870-022-03433-y.


Dysregulation of nitric oxide synthases during early and late pathophysiological conditions of diabetes mellitus leads to amassing of microvascular impedement.

Suresh V, Reddy A J Diabetes Metab Disord. 2021; 20(1):989-1002.

PMID: 34178871 PMC: 8212285. DOI: 10.1007/s40200-021-00799-y.


PTP-MEG2 regulates quantal size and fusion pore opening through two distinct structural bases and substrates.

Xu Y, Chen X, Yang Z, Xiao P, Liu C, Li K EMBO Rep. 2021; 22(5):e52141.

PMID: 33764618 PMC: 8097337. DOI: 10.15252/embr.202052141.